CD8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
Author(s) -
Vamsee Mallajosyula,
Conner Ganjavi,
Saborni Chakraborty,
Alana M. McSween,
Ana Jimena Pavlovitch-Bedzyk,
Julie Wilhelmy,
Allison Nau,
Monali Manohar,
Kari C. Nadeau,
Mark M. Davis
Publication year - 2021
Publication title -
science immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.abg5669
Subject(s) - coronavirus , epitope , virology , covid-19 , antigen , biology , cd8 , disease , conserved sequence , immunology , base sequence , medicine , gene , genetics , infectious disease (medical specialty) , pathology , outbreak
A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here we report development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin "spheromer" displaying 12 peptide-MHC complexes. Spheromers stain specific T cells more efficiently than peptide-MHC tetramers and capture a broader portion of the sequence repertoire for a given peptide-MHC. Analyzing the response in unexposed individuals, we find that T cells recognizing peptides conserved amongst coronaviruses are more abundant and tend to have a "memory" phenotype, compared to those unique to SARS-CoV-2. Significantly, CD8 + T cells with these conserved specificities are much more abundant in COVID-19 patients with mild disease versus those with a more severe illness, suggesting a protective role.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom